• Profile
Close

The cost-effectiveness of a point-of-care paper transaminase test for monitoring treatment of HIV/TB co-infected persons

Open Forum Infectious Diseases Sep 14, 2017

Rajasingham R, et al. - Authors aimed to assess the cost-effectiveness of a point-of-care paper transaminase test for monitoring treatment of HIV/tuberculosis (TB) co-infected persons. At its current performance, monthly drug-induced liver injury (DILI) monitoring by bin placement using the paper-based test proved cost-effective, compared to clinical monitoring, in HIV/TB co-infected persons in South Africa.
Full text available Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
  • Exclusive Write-ups & Webinars by KOLs

  • Nonloggedininfinity icon
    Daily Quiz by specialty
  • Nonloggedinlock icon
    Paid Market Research Surveys
  • Case discussions, News & Journals' summaries
Sign-up / Log In
x
M3 app logo
Choose easy access to M3 India from your mobile!


M3 instruc arrow
Add M3 India to your Home screen
Tap  Chrome menu  and select "Add to Home screen" to pin the M3 India App to your Home screen
Okay